|
C7ORF70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62658775337832E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-15 |
| Normal-vs-Stage2 |
2.96810354072363E-11 |
| Normal-vs-Stage3 |
8.88178419700125E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.105190E-01 |
| Stage1-vs-Stage3 |
6.160600E-01 |
| Stage1-vs-Stage4 |
5.174400E-02 |
| Stage2-vs-Stage3 |
7.262200E-02 |
| Stage2-vs-Stage4 |
6.524700E-03 |
| Stage3-vs-Stage4 |
1.676360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33226762955019E-15 |
| Normal-vs-AfricanAmerican |
4.23738821808683E-12 |
| Normal-vs-Asian |
9.43689570931383E-15 |
| Caucasian-vs-AfricanAmerican |
6.162000E-01 |
| Caucasian-vs-Asian |
9.826200E-01 |
| AfricanAmerican-vs-Asian |
6.496200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62581059726108E-12 |
| Normal-vs-Female |
1.62680979798324E-12 |
| Male-vs-Female |
7.902800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62858615482264E-12 |
| Normal-vs-Age(61-80Yrs) |
6.99440505513849E-15 |
| Normal-vs-Age(81-100Yrs) |
1.386680E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.710980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.270000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.869200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.527800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.675600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.623000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.291700E-02 |
| Classical-VS-Follicular |
4.289800E-01 |
| Classical-VS-Other |
8.976800E-01 |
| Classical-VS-Normal |
1.6538992397841E-12 |
| Tall-VS-Follicular |
1.093580E-02 |
| Tall-VS-Other |
3.217800E-01 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
7.286000E-01 |
| Follicular-VS-Normal |
2.09721129351692E-12 |
| Other-VS-Normal |
3.192000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7715611723761E-15 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
8.782500E-04 |
|
|
